QP 15 - GU 8: Quick Pitch: Novel Concepts in Localized Prostate Cancer

Presentations

• 05:15pm - 06:15pm PT

  GU 8: Quick Pitch: Novel Concepts in Localized Prostate Cancer

  Speaker: Praveen Pendyala, MD - Cleveland Clinic Taussig Cancer Center, Cleveland
• 05:15pm - 06:15pm PT

  GU 8: Quick Pitch: Novel Concepts in Localized Prostate Cancer

  Speaker: Nicholas Zaorsky, MD, MS - University Hospitals, Cleveland
• 05:20pm - 05:25pm PT

  5-Year Results of a Prospective, Non-Randomized Controlled Study: Comparison of the Efficacy and Safety of ADT + Docetaxel vs. ADT + Novel Hormone Therapy in High Gleason Score Non-Metastatic Prostate

  Speaker: Mingwei Ma, MD - Peking University First Hospital, Beijing
• 05:20pm - 05:25pm PT

  Prospective Phase II Trial of Short Course Androgen Deprivation, Pelvic SBRT, and Brachytherapy Boost for NCCN High-Risk Prostate Cancer with Low-Intermediate Risk Decipher Genomic Score

  Speaker: Alexander Goglia, MD, PhD - Memorial Sloan Kettering Cancer Center, New York
• 05:25pm - 05:30pm PT

  A Phase I/Ib, Single Arm Study of Two Fraction SBRT with SIB for the Treatment of Localized Prostate Cancer: Early Toxicity Outcomes

  Speaker: Jonathan Lischalk, MD - NYU Langone Health - Long Island, Mineola
• 05:30pm - 05:35pm PT

  Identifying Optimal Candidates for PSMA PET Staging of Newly Diagnosed Intermediate Risk Prostate Cancer: A Report from the National Veterans Affairs System

  Speaker: Joseph Tang, MD, BS - University of Michigan, Ann Arbor
• 05:35pm - 05:40pm PT

  Moderate Hypofractionated Boost to the Prostate with Pelvic Radiotherapy in High-Risk Prostate Cancer (MOB-RT): Early Outcomes from a Non-Randomized Phase II Trial

  Speaker: James Bernstein, - Dalhousie University, Halifax
• 05:40pm - 05:45pm PT

  PURE-MRI: An International Study Assessing Physician Accuracy in Delineating the Prostate and Urethra on Prostate MRI

  Speaker: Lily Nguyen, BS - UCSD Medical School, La Jolla
• 05:45pm - 05:50pm PT

  Treatment Outcomes and Prognostic Factors of Carbon Ion Radiation Therapy for Localized Prostate Cancer: A Single-Institution Retrospective Study of over 7000 Patients

  Speaker: Kaori Fukunishi, MD - SAGA-HIMAT Foundation, Ion Beam Therapy Center, Tosu